- Home
- DTIL vs ANVS Comparison
DTIL vs ANVS Comparison
Compare DTIL & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTIL
- ANVS
- Stock Information
- Founded
- DTIL 2006
- ANVS 2008
- Country
- DTIL United States
- ANVS United States
- Employees
- DTIL N/A
- ANVS N/A
- Industry
- DTIL Biotechnology: Pharmaceutical Preparations
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- DTIL Health Care
- ANVS Health Care
- Exchange
- DTIL Nasdaq
- ANVS Nasdaq
- Market Cap
- DTIL 55.3M
- ANVS 55.5M
- IPO Year
- DTIL 2019
- ANVS 2020
- Fundamental
- Price
- DTIL $4.61
- ANVS $2.48
- Analyst Decision
- DTIL Strong Buy
- ANVS Strong Buy
- Analyst Count
- DTIL 2
- ANVS 4
- Target Price
- DTIL $47.00
- ANVS $17.33
- AVG Volume (30 Days)
- DTIL 78.0K
- ANVS 218.3K
- Earning Date
- DTIL 11-03-2025
- ANVS 11-07-2025
- Dividend Yield
- DTIL N/A
- ANVS N/A
- EPS Growth
- DTIL N/A
- ANVS N/A
- EPS
- DTIL N/A
- ANVS N/A
- Revenue
- DTIL $1,261,000.00
- ANVS N/A
- Revenue This Year
- DTIL N/A
- ANVS N/A
- Revenue Next Year
- DTIL $135.19
- ANVS N/A
- P/E Ratio
- DTIL N/A
- ANVS N/A
- Revenue Growth
- DTIL N/A
- ANVS N/A
- 52 Week Low
- DTIL $3.61
- ANVS $1.11
- 52 Week High
- DTIL $10.71
- ANVS $10.54
- Technical
- Relative Strength Index (RSI)
- DTIL 40.75
- ANVS 52.16
- Support Level
- DTIL $4.86
- ANVS $2.26
- Resistance Level
- DTIL $5.17
- ANVS $2.51
- Average True Range (ATR)
- DTIL 0.24
- ANVS 0.12
- MACD
- DTIL -0.03
- ANVS 0.02
- Stochastic Oscillator
- DTIL 16.18
- ANVS 87.10
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.